مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

مصطلحات الفهرس: death, drug efficacy, drug safety, end stage renal disease, glomerulus filtration rate, human, kidney function, major clinical study, meta analysis, priority journal, proteinuria, randomized controlled trial, rash/si [Side Effect], review, risk benefit analysis, Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], toxic epidermal necrolysis/si [Side Effect], uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/dt [Drug Therapy], creatinine/ec [Endogenous Compound], placebo, uric acid/ec [Endogenous Compound], allopurinol/ct [Clinical Trial], aplastic anemia/si [Side Effect], blood pressure, chronic kidney disease/dt [Drug Therapy], controlled study, creatinine blood level, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42016
Click here for full text options
LibKey Link

مصطلحات الفهرس: death, drug efficacy, drug safety, end stage renal disease, glomerulus filtration rate, human, kidney function, major clinical study, meta analysis, priority journal, proteinuria, randomized controlled trial, rash/si [Side Effect], review, risk benefit analysis, Stevens Johnson syndrome/si [Side Effect], thrombocytopenia/si [Side Effect], toxic epidermal necrolysis/si [Side Effect], uric acid blood level, allopurinol/ae [Adverse Drug Reaction], allopurinol/dt [Drug Therapy], creatinine/ec [Endogenous Compound], placebo, uric acid/ec [Endogenous Compound], allopurinol/ct [Clinical Trial], aplastic anemia/si [Side Effect], blood pressure, chronic kidney disease/dt [Drug Therapy], controlled study, creatinine blood level, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42016
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug fever/si [Side Effect], drug hypersensitivity/dt [Drug Therapy], drug hypersensitivity/si [Side Effect], drug infusion, drug withdrawal, edema/dt [Drug Therapy], edema/si [Side Effect], eye inflammation/dt [Drug Therapy], eye inflammation/si [Side Effect], eyelid edema/dt [Drug Therapy], face, female, hospital admission, human, infection/dt [Drug Therapy], infection/pc [Prevention], intensive care unit, letter, maintenance drug dose, necrosis/si [Side Effect], ointment, pain/dt [Drug Therapy], petit mal/dr [Drug Resistance], petit mal/dt [Drug Therapy], scar, seizure/dt [Drug Therapy], toxic epidermal necrolysis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment failure, visual impairment/co [Complication], wound dressing, antibiotic agent/dt [Drug Therapy], antihistaminic agent/dt [Drug Therapy], antiinflammatory agent/cb [Drug Combination], antiinflammatory agent/dt [Drug Therapy], antiinflammatory agent/iv [Intravenous Drug Administration], carbomer/cb [Drug Combination], carbomer/dt [Drug Therapy], chloramphenicol/cb [Drug Combination], chloramphenicol/dt [Drug Therapy], chloramphenicol/io [Intraocular Drug Administration], eye drops/cb [Drug Combination], eye drops/dt [Drug Therapy], eye drops/io [Intraocular Drug Administration], hydrocortisone/cb [Drug Combination], hydrocortisone/dt [Drug Therapy], hydrocortisone/iv [Intravenous Drug Administration], hydroxypropylmethylcellulose/cb [Drug Combination], hydroxypropylmethylcellulose/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], lamotrigine/ae [Adverse Drug Reaction], lamotrigine/cb [Drug Combination], lamotrigine/do [Drug Dose], lamotrigine/dt [Drug Therapy], lubricating agent/cb [Drug Combination], lubricating agent/dt [Drug Therapy], narcotic analgesic agent/dt [Drug Therapy], prednisolone acetate/cb [Drug Combination], prednisolone acetate/dt [Drug Therapy], prednisolone acetate/tp [Topical Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], valproic acid/cb [Drug Combination], valproic acid/do [Drug Dose], valproic acid/dt [Drug Therapy], eyelid edema/si [Side Effect], adult, antibiotic prophylaxis, back, blister/dt [Drug Therapy], blister/si [Side Effect], case report, conjunctiva, conjunctivitis/dt [Drug Therapy], conjunctivitis/si [Side Effect], disease severity, drug eruption/dt [Drug Therapy], drug eruption/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32753
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug fever/si [Side Effect], drug hypersensitivity/dt [Drug Therapy], drug hypersensitivity/si [Side Effect], drug infusion, drug withdrawal, edema/dt [Drug Therapy], edema/si [Side Effect], eye inflammation/dt [Drug Therapy], eye inflammation/si [Side Effect], eyelid edema/dt [Drug Therapy], face, female, hospital admission, human, infection/dt [Drug Therapy], infection/pc [Prevention], intensive care unit, letter, maintenance drug dose, necrosis/si [Side Effect], ointment, pain/dt [Drug Therapy], petit mal/dr [Drug Resistance], petit mal/dt [Drug Therapy], scar, seizure/dt [Drug Therapy], toxic epidermal necrolysis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment failure, visual impairment/co [Complication], wound dressing, antibiotic agent/dt [Drug Therapy], antihistaminic agent/dt [Drug Therapy], antiinflammatory agent/cb [Drug Combination], antiinflammatory agent/dt [Drug Therapy], antiinflammatory agent/iv [Intravenous Drug Administration], carbomer/cb [Drug Combination], carbomer/dt [Drug Therapy], chloramphenicol/cb [Drug Combination], chloramphenicol/dt [Drug Therapy], chloramphenicol/io [Intraocular Drug Administration], eye drops/cb [Drug Combination], eye drops/dt [Drug Therapy], eye drops/io [Intraocular Drug Administration], hydrocortisone/cb [Drug Combination], hydrocortisone/dt [Drug Therapy], hydrocortisone/iv [Intravenous Drug Administration], hydroxypropylmethylcellulose/cb [Drug Combination], hydroxypropylmethylcellulose/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], lamotrigine/ae [Adverse Drug Reaction], lamotrigine/cb [Drug Combination], lamotrigine/do [Drug Dose], lamotrigine/dt [Drug Therapy], lubricating agent/cb [Drug Combination], lubricating agent/dt [Drug Therapy], narcotic analgesic agent/dt [Drug Therapy], prednisolone acetate/cb [Drug Combination], prednisolone acetate/dt [Drug Therapy], prednisolone acetate/tp [Topical Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], valproic acid/cb [Drug Combination], valproic acid/do [Drug Dose], valproic acid/dt [Drug Therapy], eyelid edema/si [Side Effect], adult, antibiotic prophylaxis, back, blister/dt [Drug Therapy], blister/si [Side Effect], case report, conjunctiva, conjunctivitis/dt [Drug Therapy], conjunctivitis/si [Side Effect], disease severity, drug eruption/dt [Drug Therapy], drug eruption/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32753
LibKey Link